<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/suspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/suspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-03-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2015-03-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/suspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b/"},"url":"https://clinicaltree.github.io/posts/suspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b/"}</script><title>Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1427821200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Mar 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Habib Rahbar MD</a> </em>, <em> <a href="">Jane L. Conlin MD</a> </em>, <em> <a href="">Sana Parsian MD</a> </em>, <em> <a href="">Wendy B. DeMartini MD</a> </em>, <em> <a href="">Sue Peacock MS</a> </em>, <em> <a href="">Constance D. Lehman MD PhD</a> </em>, <em> <a href="">Savannah C. Partridge PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2533 words"> <em>14 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To determine whether quantitative dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) magnetic resonance imaging (MRI) features can discriminate malignant from benign axillary lymph nodes (ALNs) identified as suspicious on clinical breast MRI in patients newly diagnosed with breast cancer.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>After approval from institutional review board, all clinical breast MR examinations performed from March 2006 through January 2010 describing at least one morphologically suspicious ipsilateral ALN in patients with newly diagnosed breast cancer were identified. Each suspicious ALN underwent ultrasound-guided core needle biopsy, and nodes with benign results were subsequently sampled surgically. Quantitative DCE and DW MRI parameters (diameters, volume, enhancement kinetics, and apparent diffusion coefficients [ADC]) were measured for each suspicious ALN and a representative contralateral normal node, and each feature was compared between the ALN groups (normal, benign, and malignant).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Thirty-four suspicious ALNs (18 malignant and 16 benign) and 34 contralateral normal-appearing ALNs were included. Suspicious malignant and benign nodes exhibited larger size, greater volume, and lower ADCs than normal ALNs ( <em>P</em> &lt; .05). Among suspicious ALNs, the only quantitative measure that discriminated between malignant from benign outcome was percent of ALN demonstrating washout kinetics ( <em>P</em> = .02).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In ALNs deemed morphologically suspicious on breast MRI, quantitative MRI features show little value in identifying those with malignant etiology.</p><p>Axillary lymph node (ALN) status in patients newly diagnosed with invasive breast cancer provides vital prognostic information to guide therapy. In clinically node-negative women with T1 or T2 invasive breast cancer, determination of ALN status has evolved from routine surgical removal of all level I and II ALNs with complete axillary lymph node dissection (ALND) to the modern practice of selective surgical sampling of a few (typically less than five) level I ALNs to exclude the presence of axillary nodal metastases with sentinel lymph node biopsy (SLNB). This less-invasive strategy results in completion ALND in only those patients with SLNB-proven lymph node metastases, has proven to be highly accurate, and allows most patients to avoid ALND and its associated high rate of morbidity . The use of ALND is expected to decline further since recent data from the American College of Surgery Oncology Group (ACOSOG) Z0011 trial showed a lack of survival or locoregional recurrence benefit of completion ALND in clinically node-negative but SLNB-positive women .</p><p>Although surgical evaluation of the axilla continues to trend toward less-extensive operations, the role of imaging in axillary assessments needs to evolve with surgical technique accordingly. Several recent studies have suggested breast magnetic resonance imaging (MRI) features of ALNs , and breast primary malignancies may hold promise to confirm the presence or absence of metastatic ALNs. Because breast MRI is increasingly being used at centers for preoperative evaluation of patients newly diagnosed with breast cancer, this potential added benefit is appealing . However, given new trends in management of the axilla in the post-ACOSOG Z0011 era, determining the presence of one or more ALN metastases that are not clinically suspicious but are detected solely by imaging may provide less clinical utility than determining the number of disease-laden ALNs by SLNB. Thus, we sought to assess the ability of quantitative dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) MRI features to improve the positive predictive value (PPV) of clinical breast MRI assessments of morphologically suspicious ALNs using direct pathology-to-imaging verification.</p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patient-population"><span class="mr-2">Patient Population</span><a href="#patient-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-technique"><span class="mr-2">MRI Technique</span><a href="#mri-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>(4/3π×abc)8 (</p><p>4</p><p>/</p><p>3</p><p>π</p><p>×</p><p>abc</p><p>)</p><p>8</p><p>where a, b, and c are the three orthogonal diameters (AP, ML, and SI).</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SuspiciousAxillaryLymphNodesIdentifiedonClinicalBreastMRIinPatientsNewlyDiagnosedwithBreastCancer/0_1s20S1076633214004012.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SuspiciousAxillaryLymphNodesIdentifiedonClinicalBreastMRIinPatientsNewlyDiagnosedwithBreastCancer/0_1s20S1076633214004012.jpg" alt="Figure 1, A 57-year-old woman presented with a 26-mm invasive ductal carcinoma (IDC) in the left breast for a bilateral breast magnetic resonance imaging (MRI) to assess extent of disease with dynamic contrast-enhanced (DCE) and diffusion-weighted imaging (DWI) techniques. (a) Regional nonmass enhancement ( red circle ) is present in the left breast on maximum intensity projection image, site of biopsy-proven IDC ( red circle ) in the left breast. (b) Initial-phase postcontrast T1-weighted image with fat suppression demonstrates a morphologically suspicious level 1 axillary lymph node (ALN) in the left axilla ( vertical orange arrow ) and a representative contralateral morphologically normal level 1 ALN ( angled blue arrow ) in an analogous location. (c) Both the suspicious ALN ( vertical orange arrow ) and normal ALN ( angled blue arrow ) exhibit high signal intensity on DWI. (d) Both the suspicious ALN ( vertical orange arrow ) and normal ALN ( angled blue arrow ) are dark on ADC map (d) confirming the presence of restricted diffusion. (e) Sagittally oriented, contrast-enhanced, T1-weighted, fat-suppressed reformations demonstrate the morphology of the suspicious ALN ( vertical orange arrow ) in the breast ipsilateral to the IDC. (f) Morphology of the suspicious ALN on ultrasound ( angled orange arrow ) that ultimately underwent ultrasound-guided biopsy correlates well with morphologic appearance on MRI (b,e) . (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>ADC=−(1b)ln(SDWIS0) ADC</p><p>=</p><p>−</p><p>(</p><p>1</p><p>b</p><p>)</p><p>ln</p><p>(</p><p>S</p><p>DWI</p><p>S</p><p>0</p><p>)</p><p>where <em>b</em> = 600 s/mm 2 , S DWI is the combined DW image (geometric average of individual <em>b</em> = 600 s/mm 2 DW images), and <em>S</em> 0 is the <em>b</em> = 0 s/mm 2 reference image.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Ratio=[suspiciousALNvalue][normalALNvalue] Ratio</p><p>=</p><p>[</p><p>suspicious</p><p>ALN</p><p>value</p><p>]</p><p>[</p><p>normal</p><p>ALN</p><p>value</p><p>]</p><p>where ratio is the intrapatient ratio for a given MRI parameter, suspicious ALN value is the measured value for that MRI parameter for a given patient, and normal ALN value is the measured value for that MRI parameter for the same patient.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="aln-ultrasound-cnb-technique"><span class="mr-2">ALN Ultrasound CNB Technique</span><a href="#aln-ultrasound-cnb-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histopathology"><span class="mr-2">Histopathology</span><a href="#histopathology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Index Tumor Characteristics for All Patients Included in the Study</p><p>Characteristic Benign ALN ( <em>N</em> = 16) Malignant ALN ( <em>N</em> = 18) Total ( <em>N</em> = 34) Maximum tumor size, mm; median (range) 17 (9–45) 18 (11–29) 17 (9–45) Tumor histology, <em>n</em> (%) DCIS 1 (6.3) 0 (0) 1 (2.9) IDC 13 (81.3) 15 (83.3) 28 (82.4) ILC 1 (6.3) 3 (16.7) 4 (11.8) Poorly differentiated carcinoma 1 (6.3) 0 (0) 1 (2.9) Nottingham Score, <em>n</em> (%) 1 2 (12.5) 2 (11.1) 4 (11.8) 2 5 (32.3) 6 (33.3) 11 (32.4) 3 7 (43.8) 10 (55.6) 17 (50.0) Not assessed (DCIS and poorly differentiated carcinoma) 2 (12.5) 0 (0) 2 (5.6) Estrogen receptor, <em>n</em> (%) Positive 6 (37.5) 12 (66.7) 18 (52.9) Negative 9 (56.3) 6 (33.3) 15 (44.1) Unknown 1 (6.3) 0 (0) 1 (2.9) Progesterone receptor, <em>n</em> (%) Positive 4 (25.0) 11 (61.1) 15 (44.1) Negative 9 (56.3) 7 (38.9) 16 (47.1) Unknown 3 (19.0) 0 (0) 3 (8.8) HER2/neu receptor, <em>n</em> (%) Positive 0 (0) 3 (16.7) 3 (8.8) Negative 12 (75.0) 14 (77.8) 26 (76.5) Unknown 4 (25.0) 1 (2.6) 5 (14.7) Ki-67 (%), mean (range) 53.8 (5–90) 38 (5–80) 45.4 (5–90)</p><p>DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="suspicious-malignant-outcome-versus-normal-aln-comparisons"><span class="mr-2">Suspicious Malignant Outcome Versus Normal ALN Comparisons</span><a href="#suspicious-malignant-outcome-versus-normal-aln-comparisons" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Comparison of Quantitative MRI Features of Malignant Versus Contralateral Normal Axillary Lymph Nodes (ALNs) in 34 Patients with Breast Cancer</p><p>Feature Malignant ALN, mean (SD) Normal ALN, mean (SD)<em>P</em> Value Kinetic features Peak enhancement (%) 440.6 (299.0) 324.8 (226.9) .11 Washout (%) 73.4 (20.9) 72.4 (20.7) .80 Size Angiographic volume (mm 3 ) 1.8 (1.9) 0.4 (0.3) &lt;.0001 ∗ Manual volume (mm 3 ) 2.0 (1.7) 0.4 (0.3) &lt;.0001 ∗ Maximum size (mm) 19.4 (5.2) 12.6 (5.7) .0008 ∗ Minimum size (mm) 10.6 (3.2) 5.7 (2.1) &lt;.0001 ∗ DW MRI features Mean ADC (mm 2 /s) 1.01 (0.2) 1.14 (0.2) .02 ∗ Minimum ADC (mm 2 /s) 0.51 (0.2) 0.73 (0.3) .002 ∗</p><p>ADC, apparent diffusion coefficient; DW, diffusion weighted; MRI, magnetic resonance imaging; SD, standard deviation.</p><p><em>P</em> values were calculated by Wilcoxon signed rank test.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SuspiciousAxillaryLymphNodesIdentifiedonClinicalBreastMRIinPatientsNewlyDiagnosedwithBreastCancer/1_1s20S1076633214004012.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SuspiciousAxillaryLymphNodesIdentifiedonClinicalBreastMRIinPatientsNewlyDiagnosedwithBreastCancer/1_1s20S1076633214004012.jpg" alt="Figure 2, A 43-year-old woman with a new diagnosis of right breast Nottingham grade 2 invasive ductal carcinoma spanning 20 mm in maximal size presents for a bilateral breast magnetic resonance imaging (MRI) to evaluate extent of disease. A suspicious and ultimately biopsy-proven malignant ipsilateral axillary lymph node (ALN) was identified on the MRI. (a) The suspicious ALN ( arrow ) demonstrated diffuse cortical thickening and loss of fatty hilum on this T1-weighted contrast-enhanced image with fat suppression. (b) The suspicious ALN exhibited 308% initial peak enhancement with 83% delayed washout ( red color overlay ) on computer-aided evaluation. (c) The ALN exhibits high signal ( arrow ) on the b = 600 s/mm 2 diffusion-weighted image. (d) On apparent diffusion coefficient (ADC) map, the ALN is dark ( arrow ; mean ADC, 0.65 × 10 −3 mm 2s), indicating restricted diffusion. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="suspicious-benign-outcome-versus-normal-aln-comparisons"><span class="mr-2">Suspicious Benign Outcome Versus Normal ALN Comparisons</span><a href="#suspicious-benign-outcome-versus-normal-aln-comparisons" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Comparison of Quantitative MRI Features of Benign Versus Contralateral Normal Axillary Lymph Nodes (ALNs) in 34 Patients with Breast Cancer</p><p>Feature Benign ALN, mean (SD) Normal ALN, mean (SD)<em>P</em> Value Kinetic features Peak enhancement (%) 398.7 (225.9) 411.7 (470.7) .38 Washout (%) 88.4 (12.8) 82.8 (16.8) .4 Size Angiographic volume (mm 3 ) 3.2 (4.5) 0.5 (0.6) .001 ∗ Manual volume (mm 3 ) 3.5 (5.9) 0.8 (0.7) .0002 ∗ Maximum size (mm) 20.7 (9.9) 14.9 (6.3) .06 Minimum size (mm) 12.5 (5.3) 6.8 (2.8) &lt;.0001 ∗ DW MRI features Mean ADC (mm 2 /s) 1.03 (0.2) 1.12 (0.2) .08 Minimum ADC (mm 2 /s) 0.44 (0.2) 0.69 (0.3) .003 ∗</p><p>ADC, apparent diffusion coefficient; DW, diffusion weighted; MRI, magnetic resonance imaging; SD, standard deviation.</p><p><em>P</em> values were calculated by Wilcoxon signed rank test.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SuspiciousAxillaryLymphNodesIdentifiedonClinicalBreastMRIinPatientsNewlyDiagnosedwithBreastCancer/2_1s20S1076633214004012.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SuspiciousAxillaryLymphNodesIdentifiedonClinicalBreastMRIinPatientsNewlyDiagnosedwithBreastCancer/2_1s20S1076633214004012.jpg" alt="Figure 3, A 40-year-old woman with newly diagnosed high nuclear grade ductal carcinoma in situ spanning 50 mm in the right breast presents for bilateral breast magnetic resonance imaging (MRI) to evaluate extent of disease. A suspicious and ultimately biopsy-proven benign (on both core needle biopsy and sentinel lymph node biopsy) ipsilateral axillary lymph node (ALN) was identified on the MRI. The asymmetrical size and suspicious morphology of this lymph node were presumed to be due to reactive changes from recent ipsilateral breast biopsy performed 1 week before the MRI. (a) T1-weighted, fat-suppressed, contrast-enhanced axial image demonstrates the suspicious ALN ( arrow ) measuring 29 mm in maximal size and exhibiting diffuse cortical thickening and loss of fatty hilum. (b) The suspicious ALN exhibited 308% initial peak enhancement with 83% delayed washout ( red color overlay ) on computer-aided evaluation. (c) On diffusion-weighted imaging (DWI), the ALN exhibits high signal on the b = 600 s/mm 2 image ( orange arrow ). (d) The suspicious ALN is dark on the apparent diffusion coefficient (ADC) map ( arrow ; mean ADC, 0.78 × 10 −3 mm 2s), indicating restricted diffusion. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="suspicious-malignant-outcome-versus-benign-outcome-aln-comparisons"><span class="mr-2">Suspicious Malignant Outcome Versus Benign Outcome ALN Comparisons</span><a href="#suspicious-malignant-outcome-versus-benign-outcome-aln-comparisons" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Comparison of Quantitative MRI Features between Benign and Malignant Morphologically Suspicious Axillary Lymph Nodes (ALNs)</p><p>Feature Benign ALN, mean (SD) Malignant ALN, mean (SD)<em>P</em> Value Kinetic features Peak enhancement (%) 398.7 (225.9) 440.6 (299.0) .63 Washout (%) 88.4 (12.8) 73.4 (20.9) .03 ∗ Size Angiographic volume (mm 3 ) 3.2 (4.5) 1.8 (1.9) .68 Manual volume (mm 3 ) 3.5 (5.9) 2.0 (1.7) .61 Maximum size (mm) 20.7 (9.9) 19.4 (5.2) .96 Minimum size (mm) 12.5 (5.3) 10.6 (3.2) .30 DW MRI features Mean ADC (mm 2 /s) 1.03 (0.2) 1.01 (0.2) .62 Minimum ADC (mm 2 /s) 0.44 (0.2) 0.5 (0.2) .39</p><p>ADC, apparent diffusion coefficient; DW, diffusion weighted; MRI, magnetic resonance imaging; SD, standard deviation.</p><p><em>P</em> values were calculated by Mann–Whitney <em>U</em> test.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 5</p><p>Comparison of Intraindividual Normalized Quantitative MRI Features between Benign and Malignant Morphologically Suspicious Axillary Lymph Nodes (ALN)</p><p>Feature Benign ALN, mean (SD) Malignant ALN, mean (SD)<em>P</em> Value Kinetic feature ratios Peak enhancement 1.43 (1.3) 2.0 (2.4) .26 Washout 1.12 (0.3) 1.11 (0.5) .96 Size ratios Angiographic volume ratio 1.17 (1.6) 1.05 (1.2) .77 Manual volume ratio 4.96 (5.0) 9.38 (16.4) .15 Maximum size 1.52 (0.7) 1.91 (1.3) .39 Minimum size 1.95 (0.7) 1.99 (0.8) .93 DW MRI feature ratios Mean ADC ratio 0.95 (0.2) 0.90 (0.2) .40 Minimum ADC ratio 0.70 (0.4) 0.85 (0.8) .99</p><p>ADC, apparent diffusion coefficient; DW, diffusion weighted; MRI, magnetic resonance imaging; SD, standard deviation.</p><p>All values are ratios of suspicious ALN-to-contralateral normal ALN, and thus, there are no units.</p><p><em>P</em> values were calculated by Wilcoxon rank sum test.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Martin R.C., Chagpar A., Scoggins C.R., et. al.: Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005; 241: pp. 1005-1012. discussion 12–5</p><li><p>2. Veronesi U., Paganelli G., Viale G., et. al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: pp. 546-553.</p><li><p>3. Giuliano A.E., Hunt K.K., Ballman K.V., et. al.: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305: pp. 569-575.</p><li><p>4. He N., Xie C., Wei W., et. al.: A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. Eur J Radiol 2012; 81: pp. 2602-2612.</p><li><p>5. Junping W., Tongguo S., Yunting Z., et. al.: Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity. J Magn Reson Imaging 2012; 36: pp. 624-631.</p><li><p>6. Kamitani T., Hatakenaka M., Yabuuchi H., et. al.: Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer. Clin Imaging 2013; 37: pp. 56-61.</p><li><p>7. Luo N., Su D., Jin G., et. al.: Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients. J Magn Reson Imaging 2013; 38: pp. 824-828.</p><li><p>8. Scaranelo A.M., Eiada R., Jacks L.M., et. al.: Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Radiology 2012; 262: pp. 425-434.</p><li><p>9. Loiselle C., Eby P.R., Kim J.N., et. al.: Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy. Acad Radiol 2014; 21: pp. 92-98.</p><li><p>10. Lehman C.D., DeMartini W., Anderson B.O., et. al.: Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw 2009; 7: pp. 193-201.</p><li><p>11. Lehman C.D., Gatsonis C., Kuhl C.K., et. al.: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: pp. 1295-1303.</p><li><p>12. Mortellaro V.E., Marshall J., Singer L., et. al.: Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging 2009; 30: pp. 309-312.</p><li><p>13. Rahbar H., Partridge S.C., Javid S.H., et. al.: Imaging axillary lymph nodes in patients with newly diagnosed breast cancer. Curr Probl Diagn Radiol 2012; 41: pp. 149-158.</p><li><p>14. Krammer J., Engel D., Nissen J., et. al.: Characteristics of axillary lymph nodes apparent on dynamic contrast-enhanced breast MRI in healthy women. Clin Imaging 2012; 36: pp. 249-254.</p><li><p>15. Partridge S.C., Rahbar H., Murthy R., et. al.: Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med 2011; 65: pp. 1759-1767.</p><li><p>16. Amersi F., Giuliano A.E.: Management of the axilla. Hematol Oncol Clin North Am 2013; 27: pp. 687-702.</p><li><p>17. Murray A.D., Staff R.T., Redpath T.W., et. al.: Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 2002; 75: pp. 220-228.</p><li><p>18. Valente S.A., Levine G.M., Silverstein M.J., et. al.: Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol 2012; 19: pp. 1825-1830.</p><li><p>19. Kvistad K.A., Rydland J., Smethurst H.B., et. al.: Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000; 10: pp. 1464-1471.</p><li><p>20. Baltzer P.A., Dietzel M., Burmeister H.P., et. al.: Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol 2011; 196: pp. W641-W647.</p><li><p>21. Fornasa F., Nesoti M.V., Bovo C., et. al.: Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer. J Magn Reson Imaging 2012; 36: pp. 858-864.</p><li><p>22. Demartini W.B., Rahbar H.: Breast magnetic resonance imaging technique at 1.5 t and 3 t: requirements for quality imaging and American College of Radiology accreditation. Magn Reson Imaging Clin N Am 2013; 21: pp. 475-482.</p><li><p>23. Rahbar H., Partridge S.C., DeMartini W.B., et. al.: Clinical and technical considerations for high quality breast MRI at 3 Tesla. J Magn Reson Imaging 2013; 37: pp. 778-790.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-4/'>Issue 4</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Suspicious%20Axillary%20Lymph%20Nodes%20Identified%20on%20Clinical%20Breast%20MRI%20in%20Patients%20Newly%20Diagnosed%20with%20Breast%20Cancer%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fsuspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Suspicious%20Axillary%20Lymph%20Nodes%20Identified%20on%20Clinical%20Breast%20MRI%20in%20Patients%20Newly%20Diagnosed%20with%20Breast%20Cancer%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fsuspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fsuspicious-axillary-lymph-nodes-identified-on-clinical-breast-mri-in-patients-newly-diagnosed-with-b%2F&text=Suspicious%20Axillary%20Lymph%20Nodes%20Identified%20on%20Clinical%20Breast%20MRI%20in%20Patients%20Newly%20Diagnosed%20with%20Breast%20Cancer%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/acute-stroke-imaging/"><div class="card-body"> <em class="small" data-ts="1427821200" data-df="ll" > Mar 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Acute Stroke Imaging</h3><div class="text-muted small"><p> Rationale and Objectives Magnetic resonance (MR) imaging (MRI) provides information that can be used to estimate the symptom onset in patients with wake-up stroke (WUS). Time-resolved MR angiograp...</p></div></div></a></div><div class="card"> <a href="/posts/assessment-of-liver-function-and-liver-fibrosis-with-dynamic-gd-eob-dtpa-enhanced-mri/"><div class="card-body"> <em class="small" data-ts="1427821200" data-df="ll" > Mar 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Liver Function and Liver Fibrosis with Dynamic Gd-EOB-DTPA–Enhanced MRI</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate the ability of segmental linear fitting analysis of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid liver perfusion magnetic resonance imaging (MRI...</p></div></div></a></div><div class="card"> <a href="/posts/can-the-signal-to-noise-ratio-of-choline-in-magnetic-resonance-spectroscopy-reflect-the-aggressivene/"><div class="card-body"> <em class="small" data-ts="1427821200" data-df="ll" > Mar 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Can the Signal-to-Noise Ratio of Choline in Magnetic Resonance Spectroscopy Reflect the Aggressiveness of Endometrial Cancer?</h3><div class="text-muted small"><p> Rationale and Objectives To differentiate endometrial cancer (ECa) from benign lesions in endometrial or in submucosa (BLs-ESm), and investigate whether the signal-to-noise ratio (SNR) of choline-...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/performance-comparison-of-1-5-t-endorectal-coil-mri-with-3-0-t-nonendorectal-coil-mri-in-patients-wi/" class="btn btn-outline-primary" prompt="Older"><p>Performance Comparison of 1.5-T Endorectal Coil MRI with 3.0-T Nonendorectal Coil MRI in Patients with Prostate Cancer</p></a> <a href="/posts/time-resolved-mr-angiography-in-wake-up-stroke/" class="btn btn-outline-primary" prompt="Newer"><p>Time-Resolved MR Angiography in Wake-up Stroke</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
